Purchase Order W81K0024P0054
Award Date 4/1/24
Potential Completion Date 3/31/25
Potential Value $443K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Johnson South, LA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, received a $14,185.00 firm fixed-price contract award from the Defense Health Agency on January 6, 2026, for test and measurement supplies for medical laboratory use. This is a Blanket Purchase Agreement (BPA) call with performance extending through September 30, 2026, and will be performed in North Chicago, Illinois. No small business set-aside was utilized for this award, demonstrating Abbott's ability to compete effectively in...
- This federal contract award is for REAGENTS, valued at $48,861.66, awarded to Abbott Laboratories Inc. by the Defense Health Agency. The contract is a Blanket Purchase Agreement (BPA) Call with a firm fixed price, and the ultimate completion date is September 30, 2025. The contract is not set aside for any specific business type. Abbott Laboratories Inc. is a global healthcare company that specializes in medical devices, diagnostic products, pharmaceuticals, and nutritional goods. The company...
- The federal contract award FA301624A0044|HT009025FG0130016 was issued to Abbott Laboratories Inc., a global healthcare company, to provide REAGENT TEST KITS. The award has a ceiling value of $40,106.39 and is a Blanket Purchase Agreement (BPA) Call under a contract vehicle with the Defense Health Agency (DHA), a defense agency. The contract is for a firm fixed-price and has an ultimate completion date of September 30, 2025. No set-aside designation was used for this award. Abbott Laboratories...
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a Blanket Purchase Agreement (BPA) call valued at $14,697.82 on January 16, 2026, by the Defense Health Agency to provide required operating procedures and supplies for a medical treatment facility located in North Chicago, Illinois. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2026. No small business set-aside designation was applied to this...
- This is a federal contract award to Abbott Laboratories Inc., a global healthcare company, by the Defense Health Agency (DHA). The contract is for REAGENTS and has a ceiling value of $99,111.10. It is a Blanket Purchase Agreement (BPA) call order, with a firm fixed price pricing type. The contract does not have a set-aside designation. The award date is May 2, 2025, and the ultimate completion date is September 30, 2025. Abbott Laboratories Inc. is the prime contractor and has extensive...
- This federal contract award is to Abbott Laboratories Inc., through its Abbott Diagnostics Division, for the delivery of REAGENTS - ALINITY S to the Defense Health Agency. The single-award, firm-fixed-price delivery order has a ceiling value of $359,037.17 and a completion date of November 24, 2023. The contract is not set aside. Abbott Laboratories is a large, global healthcare company that provides a broad range of medical devices, diagnostic products, and clinical services to various U.S....
- The Department of the Army Medical Command awarded a firm fixed price purchase order contract to Abbott Laboratories Inc. to provide an architect analyzer for chemistry and immunoassay testing. The contract period of performance is from October 1, 2022 to September 30, 2023 and the potential value is $178,501.00. The contract is not set aside for any specific business type. As a major medical device and pharmaceutical manufacturer, Abbott Laboratories provides a wide range of healthcare products...
- This is a federal contract award to Abbott Laboratories Inc., a global healthcare company, by the Defense Health Agency. The contract is for the delivery of immunochemistry reagents, with a ceiling value of $1,024,765.02 and a performance period ending on March 31, 2025. It is a firm fixed-price delivery order contract, without any set-aside designation. Abbott Laboratories Inc. holds multiple significant Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with federal...
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, received a delivery order award from the Defense Health Agency on June 29, 2021, for clinical chemistry and immunoassay products and services. The contract, valued at $2.02 million with a completion date of March 31, 2026, will be performed in Pensacola, Florida, and is structured as a firm fixed-price delivery order under the General Services Administration's Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III)....
- This is a contract awarded by the Defense Health Agency (DHA) to Abbott Laboratories Inc. through the Abbott Diagnostics Division. The contract, valued at $200,000.00, is for the provision of reagents. It is a Blanket Purchase Agreement (BPA) call order, with a firm fixed price pricing type. The ultimate completion date for this contract is September 30, 2017. Abbott Laboratories is a for-profit organization and manufacturer of goods that has provided a wide variety of medical devices,...